Results 11 to 20 of about 3,916,339 (374)
C-Reactive Protein as a Biomarker for Major Depressive Disorder?
International Journal of Molecular Sciences, 2022 The etiopathogenesis of depression is not entirely understood. Several studies have investigated the role of inflammation in major depressive disorder. The present work aims to review the literature on the association between C-Reactive Protein (CRP) and
L. Orsolini +4 more
semanticscholar +1 more source
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Neuroscience Bulletin, 2021 Major depressive disorder (MDD), also referred to as depression, is one of the most common psychiatric disorders with a high economic burden. The etiology of depression is still not clear, but it is generally believed that MDD is a multifactorial disease
Zezhi Li +3 more
semanticscholar +1 more source
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Frontiers in Psychiatry, 2021 Major depressive disorder (MDD) is a leading cause of distress, disability, and suicides. As per the latest WHO report, MDD affects more than 260 million people worldwide.
Ajay Sarawagi, N. Soni, A. Patel
semanticscholar +1 more source
Heliyon, 2023 Background: Depressive disorder is a common comorbidity in patients with cardiovascular diseases and is associated with increased hospitalization and death rates.
Zhigao Sun +7 more
doaj +1 more source
Animal models for the study of depressive disorder
CNS Neuroscience & Therapeutics, 2021 Depressive disorder is one of the most widespread forms of psychiatric pathology, worldwide. According to a report by the World Health Organization, the number of people with depression, globally, is increasing dramatically with each year.
Juhyun Song, Young-Kook Kim
semanticscholar +1 more source
, 2021 Major Depressive Disorder (MDD) and other disorders on the depressive spectrum are more prevalent among HIV-infected individuals than in the general population. These illnesses have a significant impact on prevention, engagement and adherence to HIV care, prognosis, illness-related disability, and quality of life.
FERRARI S +6 more
openaire +2 more sources
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
JAMA psychiatry, 2020 This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
Alan K. Davis +7 more
semanticscholar +1 more source
Major Depressive Disorder [PDF]
Neuron, 2000 In summary, MDD is a highly prevalent major medical whose pathophysiology is still poorly understood. MDD is often recurrent or chronic, and evidence suggests that genetic factors partially influence overall risk of illness but also influence the sensitivity of individuals to the depressogenic effects of environmental adversity.
Fava, Maurizio, Kendler, Kenneth S
openaire +2 more sources
'The risks of playing it safe': a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents [PDF]
, 2013 BACKGROUND Alterations in reward processing may represent an early vulnerability factor for the development of depressive disorder. Depression in adults is associated with reward hyposensitivity and diminished reward seeking may also be a feature of ...
A. Rawal +6 more
core +1 more source
Systematic review and meta-analysis: anxiety and depressive disorders in offspring of parents with anxiety disorders [PDF]
, 2019 Objective: We conducted meta-analyses to assess risk of anxiety disorders among offspring of parents with anxiety disorders and to establish whether there is evidence of specificity of risk for anxiety disorders as opposed to depression in offspring, and
Creswell, Cathy +2 more
core +1 more source